58 related articles for article (PubMed ID: 9341921)
1. DNA sequence recognition by the indolocarbazole antitumor antibiotic AT2433-B1 and its diastereoisomer.
Carrasco C; Facompré M; Chisholm JD; Van Vranken DL; Wilson WD; Bailly C
Nucleic Acids Res; 2002 Apr; 30(8):1774-81. PubMed ID: 11937631
[TBL] [Abstract][Full Text] [Related]
2. Analysis of DNA fragmentation in human uterine cervix carcinoma HeLa S3 cells treated with duocarmycins or other antitumor agents by pulse field gel electrophoresis.
Okamoto A; Okabe M; Gomi K
Jpn J Cancer Res; 1993 Jan; 84(1):93-8. PubMed ID: 8449832
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the synthesis of a unique mono-carboxylic acid antibiotic, (+)-zincophorin.
Song Z; Lohse AG; Hsung RP
Nat Prod Rep; 2009 Apr; 26(4):560-71. PubMed ID: 19642422
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors.
Lin H; Annamalai T; Bansod P; Tse-Dinh YC; Sun D
Medchemcomm; 2013 Dec; 4(12):. PubMed ID: 24363888
[TBL] [Abstract][Full Text] [Related]
5. Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents.
Giurini EF; Godla A; Gupta KH
Cancer Gene Ther; 2024 Feb; 31(2):187-206. PubMed ID: 38200347
[TBL] [Abstract][Full Text] [Related]
6. Secondary Metabolites of Actinomycetales as Potent Quorum Sensing Inhibitors Targeting Gram-Positive Pathogens: In Vitro and In Silico Study.
Desouky SE; Abu-Elghait M; Fayed EA; Selim S; Yousuf B; Igarashi Y; Abdel-Wahab BA; Mohammed Alsuhaibani A; Sonomoto K; Nakayama J
Metabolites; 2022 Mar; 12(3):. PubMed ID: 35323689
[TBL] [Abstract][Full Text] [Related]
7. Novel Carbazole-Piperazine Hybrid Small Molecule Induces Apoptosis by Targeting BCL-2 and Inhibits Tumor Progression in Lung Adenocarcinoma in Vitro and Xenograft Mice Model.
Mongre RK; Mishra CB; Prakash A; Jung S; Lee BS; Kumari S; Hong JT; Lee MS
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31450709
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis of Violacein, Structure and Function of l-Tryptophan Oxidase VioA from Chromobacterium violaceum.
Füller JJ; Röpke R; Krausze J; Rennhack KE; Daniel NP; Blankenfeldt W; Schulz S; Jahn D; Moser J
J Biol Chem; 2016 Sep; 291(38):20068-84. PubMed ID: 27466367
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.
Xiao Z; Morris-Natschke SL; Lee KH
Med Res Rev; 2016 Jan; 36(1):32-91. PubMed ID: 26359649
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.
Shaaban KA; Elshahawi SI; Wang X; Horn J; Kharel MK; Leggas M; Thorson JS
J Nat Prod; 2015 Jul; 78(7):1723-9. PubMed ID: 26091285
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive review of glycosylated bacterial natural products.
Elshahawi SI; Shaaban KA; Kharel MK; Thorson JS
Chem Soc Rev; 2015 Nov; 44(21):7591-697. PubMed ID: 25735878
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.
Peterson KE; Cinelli MA; Morrell AE; Mehta A; Dexheimer TS; Agama K; Antony S; Pommier Y; Cushman M
J Med Chem; 2011 Jul; 54(14):4937-53. PubMed ID: 21710981
[TBL] [Abstract][Full Text] [Related]
13. Facile synthesis of indole- or benzofuran-fused benzo[a]carbazole-1,4-diones using a tandem two-step reaction sequence.
Tu S; Ding C; Hu W; Li F; Yao Q; Zhang A
Mol Divers; 2011 Feb; 15(1):91-9. PubMed ID: 20229317
[TBL] [Abstract][Full Text] [Related]
14. Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
Borthakur G; Alvarado Y; Ravandi-Kashani F; Cortes J; Estrov Z; Faderl S; Ivy P; Bueso-Ramos C; Nebiyou Bekele B; Giles F
Cancer; 2008 Jul; 113(2):360-6. PubMed ID: 18473351
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.
Anizon F; Belin L; Moreau P; Sancelme M; Voldoire A; Prudhomme M; Ollier M; Sevère D; Riou JF; Bailly C; Fabbro D; Meyer T
J Med Chem; 1997 Oct; 40(21):3456-65. PubMed ID: 9341921
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and biological evaluation of indolocarbazoles, analogues of rebeccamycin, modified at the imide heterocycle.
Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Carrasco C; Ollier M; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
J Med Chem; 1998 May; 41(10):1631-40. PubMed ID: 9572888
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.
Pereira ER; Belin L; Sancelme M; Prudhomme M; Ollier M; Rapp M; Sevère D; Riou JF; Fabbro D; Meyer T
J Med Chem; 1996 Oct; 39(22):4471-7. PubMed ID: 8893841
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and biological activities of rebeccamycin analogues. Introduction of a halogenoacetyl substituent.
Moreau P; Anizon F; Sancelme M; Prudhomme M; Bailly C; Sevère D; Riou JF; Fabbro D; Meyer T; Aubertin AM
J Med Chem; 1999 Feb; 42(4):584-92. PubMed ID: 10052965
[TBL] [Abstract][Full Text] [Related]
19. Recent developments of rebeccamycin analogues as topoisomerase I inhibitors and antitumor agents.
Prudhomme M
Curr Med Chem; 2000 Dec; 7(12):1189-212. PubMed ID: 11032967
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
